论文部分内容阅读
目的探讨尼卡地平雾化吸入对小儿肺炎及并发心力衰竭的疗效。方法小儿肺炎８５例、并发疑似心衰３０例、并发心衰２４例，分别随机分成治疗组和对照组。各治疗组雾化吸入尼卡地平，各对照组雾化吸入α糜蛋白酶，疗程均３～５天。结果肺炎治疗组症状体征消失天数、经皮氧饱和度上升及Ｘ线胸片阴转率与对照组相比有显著性差异；疑似心衰治疗组４８ｈ缓解率优于对照组，有显著性差异；心衰治疗组症状体征消失时间、心率减慢、经皮氧饱和度上升均优于对照组，有显著性差异。结论尼卡地平雾化吸入对治疗小儿肺炎、防治并发心力衰竭具有良好的效果。
Objective To investigate the efficacy of nicardipine inhalation on children with pneumonia and concurrent heart failure. Methods 85 cases of children with pneumonia were complicated with suspected heart failure in 30 cases, complicated by heart failure in 24 cases, were randomly divided into treatment group and control group. Each treatment group inhaled nicardipine atomization, each control group inhaled α-chymotrypsin, treatment were 3 to 5 days. Results The number of disappearance of symptoms and signs, the increase of percutaneous oxygen saturation and the negative conversion rate of X-ray in the pneumonia group were significantly different from those in the control group. The 48-h remission rate in the suspected heart failure group was significantly higher than that in the control group ; Heart failure treatment group symptoms disappeared time, heart rate, percutaneous oxygen saturation were better than the control group, there was a significant difference. Conclusion nicardipine inhalation on the treatment of children with pneumonia, prevention and treatment of concurrent heart failure has a good effect.